BOT 1.41% 35.0¢ botanix pharmaceuticals ltd

Ann: Investor Webinar Presentation, page-47

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 323 Posts.
    lightbulb Created with Sketch. 183
    3 years ago Eli Lilly paid $1.1 billion USD to acquire Dermira, Dermira had Qbrexza and one other drug, a dermatitis drug called Lebrikizumab which still hasn’t been approved. So if we have similar sales to them, 70million first year, yeah it’s fair to say over a billion USD.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.